Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Lightrock inks partial exit from a nearly seven-year-old healthcare bet
Global investment platform Lightrock has scored a partial exit from a healthcare portfolio that it backed almost seven ......
Healthcare
Hyderabad-based drugmaker Biophore acquires API facility, hives off unit
Hyderabad-based Biophore India Pharmaceuticals Pvt Ltd is strengthening its bulk drugs manufacturing with an acquisition......
Healthcare
Contract drugmaker Biodeal snags fresh funding, eyes new markets
Biodeal Pharmaceuticals Ltd, the contract development and manufacturing organisation (CDMO) that last month provided an ......
Healthcare
Mumbai-based Zen Hospital explores majority stake sale
Mumbai-based multi-speciality hospital operator Zen Hospital is in talks with investors to raise capital through the ......
Healthcare
Prime Pharma secures maiden external funding for product, market expansion
Mumbai-based pharmaceutical manufacturer Prime Pharmaceuticals Pvt. Ltd has raised capital from external investors for ......
Healthcare
ADQ-anchored Lunate, Orbimed, Creaegis invest in Indian healthcare firm
A host of domestic and foreign institutional investors including private equity firms and pension funds are betting on a......
Healthcare
Hyderabad PE firm Sri Venture Partners to launch biotech-focussed fund
Hyderabad-based private equity firm Sri Venture Partners (SVP), which has so far deployed capital mostly through ......
Healthcare
How InvAscent valued bulk-drugs maker in latest twin deals
Healthcare-focused private equity firm InvAscent is investing in the bulk-drugs subsidiary of a Mumbai-listed company to......
Healthcare
Gujarat-based IRIS Hospitals buys local hospital operator
Tulips Healthcare Ltd, which operates under the IRIS Chain of Hospitals brand in Gujarat, is expanding its presence in ......
Healthcare
Piramal Alternatives exits healthcare investment through performing credit fund
Piramal Alternatives, the fund management arm of the Piramal Group, has exited its investment in a drugmaker after ......







